fractional IPV
PreclinicalBiologic
fractional IPV is one of 4 biologic programs targeting Immunization. It is currently in Preclinical.
1
Indications
3
Total Trials
1
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
6 competitors in Immunization
#DrugCompanyPhaseTrials
1ABRYSVO
PfizerPhase 3
HPV Vaccine
SShanghai Zerun Biotechnology Co.,Ltd
Phase 2
Measles
GSKPhase 2
fractional IPV
CCenters for Disease Control and Prevention
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Immunogenicity2 trials
Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)
Not yet recruiting·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 4·NCT06748612·1,190 enrolled
Immunization1 trial
Use of mOPV1 in Routine Immunization in Pakistan.
Unknown status·—·N/A·NCT04504539·560 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for fractional IPV. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details